1,10-phenanthroline and Hepatocellular Carcinoma studies

1,10-phenanthroline and Hepatocellular Carcinoma

1,10-phenanthroline: RN given refers to parent cpd; inhibits Zn-dependent metalloproteinases

Research Excerpts

Excerpt	Relevance	Reference
"Radioembolisation of hepatocellular carcinoma with radiolabelled Lipiodol is a method of choice."	5.40	Mixed-ligand complexes of yttrium-90 dialkyldithiocarbamates with 1,10-phenanthroline as a possible agent for therapy of hepatocellular carcinoma. ( Garin, E; Lepareur, N; Lopez, A; Noiret, N, 2014)
"Radioembolisation of hepatocellular carcinoma with radiolabelled Lipiodol is a method of choice."	1.40	Mixed-ligand complexes of yttrium-90 dialkyldithiocarbamates with 1,10-phenanthroline as a possible agent for therapy of hepatocellular carcinoma. ( Garin, E; Lepareur, N; Lopez, A; Noiret, N, 2014)

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

2 (66.67)

18.2507

2000's

0 (0.00)

29.6817

2010's

1 (33.33)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Lopez, A	1
Noiret, N	1
Garin, E	1
Lepareur, N	1
Cichy, J	1
Rose-John, S	1
Potempa, J	1
Pryjma, J	1
Travis, J	1
Czupryn, M	1
Brown, WE	1
Vallee, BL	1

Studies

Lopez, A

Noiret, N

Garin, E

Lepareur, N

Cichy, J

Rose-John, S

Potempa, J

Pryjma, J

Travis, J

Czupryn, M

Brown, WE

Vallee, BL

Other Studies

3 other studies available for 1,10-phenanthroline and Hepatocellular Carcinoma

Article	Year
Mixed-ligand complexes of yttrium-90 dialkyldithiocarbamates with 1,10-phenanthroline as a possible agent for therapy of hepatocellular carcinoma. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2014, Volume: 94 Topics: Carcinoma, Hepatocellular; Drug Stability; Ethiodized Oil; Feasibility Studies; Humans; Isotope Labe	2014
Oncostatin M stimulates the expression and release of the IL-6 receptor in human hepatoma HepG2 cells. Journal of immunology (Baltimore, Md. : 1950), 1997, Dec-01, Volume: 159, Issue:11 Topics: Alternative Splicing; Antineoplastic Agents; Carcinoma, Hepatocellular; Dexamethasone; Dose-Response	1997
Zinc rapidly induces a metal response element-binding factor. Proceedings of the National Academy of Sciences of the United States of America, 1992, Nov-01, Volume: 89, Issue:21 Topics: Base Sequence; Carcinoma, Hepatocellular; Cell Nucleus; DNA Probes; DNA-Binding Proteins; Edetic Aci	1992

Article

Year

Mixed-ligand complexes of yttrium-90 dialkyldithiocarbamates with 1,10-phenanthroline as a possible agent for therapy of hepatocellular carcinoma.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2014, Volume: 94

Topics: Carcinoma, Hepatocellular; Drug Stability; Ethiodized Oil; Feasibility Studies; Humans; Isotope Labe

2014

Oncostatin M stimulates the expression and release of the IL-6 receptor in human hepatoma HepG2 cells.

Journal of immunology (Baltimore, Md. : 1950), 1997, Dec-01, Volume: 159, Issue:11

Topics: Alternative Splicing; Antineoplastic Agents; Carcinoma, Hepatocellular; Dexamethasone; Dose-Response

1997

Zinc rapidly induces a metal response element-binding factor.

Proceedings of the National Academy of Sciences of the United States of America, 1992, Nov-01, Volume: 89, Issue:21

Topics: Base Sequence; Carcinoma, Hepatocellular; Cell Nucleus; DNA Probes; DNA-Binding Proteins; Edetic Aci

1992